What We Know About Zenagamtide's Phase 2 Trials The Type 2 Diabetes Trial NCT06542874 was a 36-week, randomized, placebo-controlled, dose-finding study in 262 adults with type 2 diabetes (baseline HbA1c 7.010.0%) on stable metformin, with or without an SGLT2 inhibitor
In Irvine and Orange County, patients often do best when they have clear guidance, a plan for managing side effects, and regular check ins to adjust the program based on real life feedback
Can low-dose naltrexone help autoimmune pain
What Form of Carnitine Should I Take Choosing the right form of carnitine depends on your specific health and fitness goals
What I noticed first was the mental freedom that came with it
This eye-opening episode reminds us of the power we hold over our own health, and how we can get back in the drivers seat at any age or life-stage